Alzheimer's disease secretase, APP substrates therefor, and uses therefor
AssigneePharmacia & Upjohn Company
InventorsMark E. Gurney, Michael J. Bienkowski, Robert L. Heinrikson, Luis A. Parodi, Riqiang Yan
Life of this patent
Estimating the term…
Abstract
The present invention provides the enzyme and enzymatic procedures for cleaving the β secretase cleavage site of the APP protein and associated nucleic acids, peptides, vectors, cells and cell isolates and assays. The invention further provides a modified APP protein and associated nucleic acids, peptides, vectors, cells, and cell isolates, and assays that are particularly useful for identifying candidate therapeutics for treatment or prevention of Alzheimer's disease.
Claims26
A method for identifying an agent that modulates the activity of Asp2 aspartyl protease, comprising the steps of:
- (a) contacting an Asp2 aspartyl protease with an amyloid precursor protein (APP) in the presence and absence of a test agent, wherein the Asp2 aspartyl protease is a recombinant polypeptide that exhibits Asp2 aspartyl protease activity involved in processing APP into amyloid beta and is expressed by a host cell transformed or transfected with a nucleic acid molecule that encodes the polypeptide and that hybridizes under the following stringent hybridization conditions to the complement of SEQ ID NO:
- 3:
- (1) hybridization at 42° C. in a hybridization buffer comprising 6×SSC and 0.1% SDS, and
- (2) washing at 65° C. in a wash solution comprising 1×SSC and 0.1% SDS;
- (b) determining the APP processing activity of the Asp2 aspartyl protease in the presence and absence of the test agent;
- and
- (c) comparing the APP processing activity of the Asp2 aspartyl protease in the presence of the test agent to the APP processing activity in the absence of the test agent to identify an agent that modulates the activity of the Asp2 aspartyl protease, wherein a modulator that is an Asp2 inhibitor reduces APP processing and a modulator that is an Asp2 agonist increases such processing.
A method for identifying an agent that inhibits the APP processing activity of a protease, comprising the steps of:
- (a) contacting a protease with an amyloid precursor protein (APP) substrate in the presence and absence of a test agent,
- wherein the protease comprises the recombinant polypeptide expressed by a cell transformed or transfected with a nucleic acid that comprises a nucleotide sequence encoding the protease, and
- wherein the protease comprises an amino acid sequence at least 95% identical to the Asp2 amino acid sequence set forth in SEQ ID NO:
- 4 or a fragment thereof that includes the aspartyl protease active site tripeptides DTG and DSG and exhibits Asp2 aspartyl protease activity involved in processing APP into amyloid beta;
- (b) determining the proteolytic processing activity of the protease toward the APP substrate in the presence and absence of the test agent;
- and
- (c) comparing the proteolytic processing activity of the protease in the presence of the test agent to the activity in the absence of the test agent to identify an agent that inhibits the APP processing activity of the protease, wherein reduced activity in the presence of the test agent identifies an agent that inhibits the APP processing activity of the protease.
A method for identifying an agent that inhibits the APP processing activity of a protease, comprising the steps of:
- (a) contacting a protease with an amyloid precursor protein (APP) substrate in the presence and absence of a test agent,
- wherein the protease comprises the recombinant polypeptide that exhibits Asp2 protease activity involved in processing APP into amyloid beta and is expressed by a cell transformed or transfected with a nucleic acid that comprises a nucleotide sequence encoding the protease, said nucleotide sequence hybridizing under the following stringent hybridization conditions to the complement of the nucleotide sequence set forth in SEQ ID NO:
- 3:
- (1) hybridization at 42° C. in a hybridization buffer comprising 6×SSC and 0.1% SDS, and
- (2) washing at 65° C. in a wash solution comprising 1×SSC and 0.1% SDS;
- (b) determining the proteolytic processing activity of the protease toward the APP substrate in the presence and absence of the test agent;
- and
- (c) comparing the proteolytic processing activity of the aspartyl protease in the presence of the test agent to the activity in the absence of the test agent to identify an agent that inhibits the APP processing activity of the protease, wherein reduced activity in the presence of the test agent identifies an agent that inhibits the APP processing activity of the protease.
A method for identifying an agent that inhibits the APP processing activity of a protease, comprising the steps of:
- (a) contacting a protease with an amyloid precursor protein (APP) substrate in the presence and absence of a test agent,
- wherein the protease comprises the recombinant polypeptide expressed by a cell transformed or transfected with a nucleic acid that comprises a nucleotide sequence encoding the protease, and
- wherein the protease comprises an amino acid sequence at least 95% identical to the Asp2 amino acid sequence set forth in SEQ ID NO:
- 4 or a fragment thereof that includes the aspartyl protease active site tripeptides DTG and DSG and exhibits Asp2 aspartyl protease activity involved in processing APP into amyloid beta;
- wherein the APP substrate is a peptide comprising a β-secretase cleavage site that comprises the formula P2-P1-P1′-P2′ (SEQ ID NO:
- 74), wherein
- P2 is an amino acid selected from K and N;
- P1 is an amino acid selected from M and L;
- P1′ is the amino acid D;
- and
- P2′ is the amino acid A,
- (b) determining the proteolytic processing activity of the protease toward the APP substrate in the presence and absence of the test agent;
- and
- (c) comparing the proteolytic processing activity of the protease in the presence of the test agent to the activity in the absence of the test agent to identify an agent that inhibits the APP processing activity of the protease, wherein reduced activity in the presence of the test agent identifies an agent that inhibits the APP processing activity of the protease.
A method for identifying an agent that inhibits the APP processing activity of a protease, comprising the steps of:
- (a) contacting a protease with an amyloid precursor protein (APP) substrate in the presence and absence of a test agent,
- wherein the protease comprises the recombinant polypeptide that exhibits Asp2 protease activity involved in processing APP into amyloid beta and is expressed by a cell transformed or transfected with a nucleic acid that comprises a nucleotide sequence encoding the protease, said nucleotide sequence hybridizing under the following stringent hybridization conditions to the complement of the nucleotide sequence set forth in SEQ ID NO:
- 3:
- (1) hybridization at 42° C. in a hybridization buffer comprising 6×SSC and 0.1% SDS, and
- (2) washing at 65° C. in a wash solution comprising 1×SSC and 0.1% SDS;
- wherein the APP substrate is a peptide comprising a β-secretase cleavage site that comprises the formula P2-P1-P1′-P2′ (SEQ ID NO:
- 74), wherein
- P2 is an amino acid selected from K and N;
- P1 is an amino acid selected from M and L;
- P1′ is the amino acid D;
- and
- P2′ is the amino acid A,
- (b) determining to proteolytic processing activity of the protease toward the APP substrate in the presence and absence of the test agent;
- and
- (c) comparing the proteolytic processing activity of the aspartyl protease in the presence of the test agent to the activity in the absence of the test agent to identify an agent that inhibits the APP processing activity of the protease, wherein reduced activity in the presence of the test agent identifies an agent that inhibits the APP processing activity of the protease.
Dependencies are inferred from the claim text.